Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...

Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, ...

The FDA is asking drugmakers to update the prescribing information on testosterone replacement therapy products to reflect clinical evidence.

The Department of Health and Human Services (HHS) announced plans on June 18 to update label information for testosterone ...

Younger Americans are falling behind on cancer screenings, testosterone therapy warnings may soon change and a rare amoeba ...

A follow-up of the T4DM trial in men with prediabetes or recent-onset type 2 diabetes show no further glycemic improvement ...

Multiple experts who reviewed the donation say the payment could qualify as a conflict because it has the potential to ...

Millions of people around the world take cholesterol-lowering medicines every day. These drugs are among the most commonly ...

The U.S. Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies ...

Federal health officials said testosterone therapy warning labels could be updated after a review found current evidence did ...

The Trump administration wants to update warning labels on testosterone replacement therapies, saying newer evidence does not ...

The SPIRIT randomized trial provides level 1 data supporting short-term testosterone therapy to manage hypogonadal men with low grade, localized prostate cancer after radical prostatectomy.